AbCellera Biologics Inc.
(ABCL)
undefined
undefined%
At close: undefined
2.80
-0.18%
After-hours Dec 13, 2024, 07:55 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY01 |
| Net Income | -146.40M | 158.52M | 153.46M | 118.92M | -2.21M | 309.00K | - |
| Depreciation & Amortization | 30.89M | 33.10M | 17.25M | 5.27M | 1.85M | 918.00K | - |
| Stock-Based Compensation | 64.18M | 49.48M | 30.65M | 8.40M | 890.23K | 615.00K | - |
| Other Working Capital | 56.01M | 51.47M | 36.74M | 16.51M | 3.78M | 3.11M | - |
| Other Non-Cash Items | -7.74M | 8.55M | 3.57M | 4.71M | 194.19K | -188.00K | - |
| Deferred Income Tax | 1.96M | -2.11M | -2.02M | 2.10M | - | - | - |
| Change in Working Capital | 13.22M | 29.82M | 41.67M | -116.70M | 1.97M | 1.91M | - |
| Operating Cash Flow | -43.88M | 277.36M | 244.58M | 22.69M | 2.69M | 3.56M | - |
| Capital Expenditures | -77.51M | -72.66M | -58.45M | -14.67M | -4.00M | -5.31M | - |
| Acquisitions | -13.69M | -25.68M | -41.78M | -106.89M | - | - | - |
| Purchase of Investments | -1.07B | -781.35M | -292.24M | -19.25M | - | - | - |
| Sales Maturities Of Investments | 910.94M | 510.63M | 27.61M | 19.25M | - | - | - |
| Other Investing Acitivies | 25.31M | 16.43M | 32.62M | 1.78M | -1.78M | - | - |
| Investing Cash Flow | -221.11M | -352.63M | -332.25M | -119.78M | -5.78M | -5.31M | - |
| Debt Repayment | 11.59M | 2.75M | 5.49M | 85.15M | 180.66K | 1.98M | - |
| Common Stock Repurchased | - | - | - | - | -11.15K | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | -1.23M | -4.38M | -9.37M | 673.16M | -10.83K | 7.59M | - |
| Financial Cash Flow | 10.36M | -1.63M | -3.89M | 683.65M | 194.83K | 12.19M | - |
| Net Cash Flow | -254.04M | -86.49M | -92.97M | 586.56M | -2.89M | 10.44M | - |
| Free Cash Flow | -121.38M | 204.70M | 186.13M | 8.02M | -1.30M | -1.74M | - |